首页 > 最新文献

Techniques and Innovations in Gastrointestinal Endoscopy最新文献

英文 中文
IF 0.9 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01
{"title":"","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":"27 2","pages":"Article 250916"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146834757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reopenable Clip-Over-the-Line Method for Troubleshooting Iatrogenic Gastrointestinal Perforations 诊断医源性胃肠道穿孔的可重新打开夹过线方法
IF 1.2 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 DOI: 10.1016/j.tige.2024.250901
Takeshi Yasuda, Narutoshi Ando, Tamae Hashimoto, Yoshiaki Kanai, Yoichi Sakamoto, Yuki Endo, Tomohiro Soda, Takako Akazawa, Tsuguhiro Matsumoto, Norihito Yamauchi, Akira Muramatsu, Hiromu Kutsumi
{"title":"Reopenable Clip-Over-the-Line Method for Troubleshooting Iatrogenic Gastrointestinal Perforations","authors":"Takeshi Yasuda, Narutoshi Ando, Tamae Hashimoto, Yoshiaki Kanai, Yoichi Sakamoto, Yuki Endo, Tomohiro Soda, Takako Akazawa, Tsuguhiro Matsumoto, Norihito Yamauchi, Akira Muramatsu, Hiromu Kutsumi","doi":"10.1016/j.tige.2024.250901","DOIUrl":"10.1016/j.tige.2024.250901","url":null,"abstract":"","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":"27 1","pages":"Article 250901"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143158116","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comparative Efficacy and Safety of Needle-Knife Fistulotomy vs Standard Cannulation: A Practical Randomized Controlled Trial 针刀造瘘与标准插管的疗效和安全性比较:一项实用的随机对照试验
IF 0.9 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 DOI: 10.1016/j.tige.2025.250941
Aleksey Novikov , Shuji Mitsuhashi , Muhammad Hassaan Bashir , Mena Bakhit , Ian Holmes , Alexander Schlachterman , Austin Chiang , David Loren , Thomas Kowalski

BACKGROUND AND AIMS

Current literature suggests that needle-knife fistulotomy (NKF) technique should be reserved for expert advanced endoscopists. The aim of this study was to evaluate the efficacy and safety of NKF compared with those of standard cannulation (SC) for primary biliary access performed by advanced endoscopists with a range of experience, including advanced endoscopy trainees.

METHODS

In total, 186 patients were randomly assigned to either NKF or SC as means of primary biliary access and 137 patients were included in the final analysis (clinicaltrials.gov; NCT06694038). The primary outcome was incidence of post–endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis. Secondary outcomes were biliary access success, time to biliary access, incidence of bleeding, and incidence of perforation.

RESULTS

Of the 137 procedures included in the study, 99 (72.3%) were carried out by advanced endoscopy trainees under supervision, 26 (19.0%) by advanced endoscopists without significant previous NKF experience, and 12 (8.8%) by an experienced advanced endoscopist with expertise in NKF. In the group that was randomized to SC, 6 (8.22%) patients developed pancreatitis vs 5 (7.81%) patients randomized to NKF arm (P = 0.93). Average time to biliary access within 20 minutes was significantly shorter with SC at 268 seconds (95% CI, 198-338 seconds) vs 380 seconds (95% CI, 292-466 seconds; P < 0.05) in the NKF arm.

CONCLUSION

NKF is a safe and effective technique for primary biliary access during ERCP performed by advanced endoscopists with a wide range of experience, with post-ERCP pancreatitis equivalent to SC. NKF, in this study, took slightly longer than SC to achieve bile duct access. Use of either or both techniques resulted in a 100% successful bile duct cannulation in patients with favorable anatomy.
背景和目的目前的文献表明针刀造瘘术(NKF)应该保留给高级内窥镜专家。本研究的目的是评估NKF与标准插管(SC)在初级胆道通路中的疗效和安全性,标准插管由具有丰富经验的高级内窥镜医师(包括高级内窥镜实习生)实施。方法共186例患者随机分配至NKF组或SC组作为初级胆道通路,137例患者被纳入最终分析(clinicaltrials.gov; NCT06694038)。主要结局是内镜后逆行胆管胰腺炎(ERCP)的发生率。次要结局是胆道通路的成功、到达胆道通路的时间、出血的发生率和穿孔的发生率。结果在纳入研究的137例手术中,99例(72.3%)由高级内窥镜培训生在监督下进行,26例(19.0%)由没有显著NKF经验的高级内窥镜医师进行,12例(8.8%)由具有NKF专业知识的经验丰富的高级内窥镜医师进行。在随机分配到SC组的患者中,6名(8.22%)患者发生胰腺炎,而随机分配到NKF组的患者中有5名(7.81%)患者发生胰腺炎(P = 0.93)。20分钟内到达胆道通路的平均时间显著缩短,SC组为268秒(95% CI, 198-338秒),而NKF组为380秒(95% CI, 292-466秒;P < 0.05)。结论在ERCP术后胰腺炎等同于SC的情况下,由经验丰富的高级内窥镜医师实施的NKF是一种安全有效的初级胆道通路技术。在本研究中,NKF比SC所需的时间稍长。在解剖结构良好的患者中,使用其中一种或两种技术均可100%成功地进行胆管插管。
{"title":"Comparative Efficacy and Safety of Needle-Knife Fistulotomy vs Standard Cannulation: A Practical Randomized Controlled Trial","authors":"Aleksey Novikov ,&nbsp;Shuji Mitsuhashi ,&nbsp;Muhammad Hassaan Bashir ,&nbsp;Mena Bakhit ,&nbsp;Ian Holmes ,&nbsp;Alexander Schlachterman ,&nbsp;Austin Chiang ,&nbsp;David Loren ,&nbsp;Thomas Kowalski","doi":"10.1016/j.tige.2025.250941","DOIUrl":"10.1016/j.tige.2025.250941","url":null,"abstract":"<div><h3>BACKGROUND AND AIMS</h3><div>Current literature suggests that needle-knife fistulotomy (NKF) technique should be reserved for expert advanced endoscopists. The aim of this study was to evaluate the efficacy and safety of NKF compared with those of standard cannulation (SC) for primary biliary access performed by advanced endoscopists with a range of experience, including advanced endoscopy trainees.</div></div><div><h3>METHODS</h3><div>In total, 186 patients were randomly assigned to either NKF or SC as means of primary biliary access and 137 patients were included in the final analysis (clinicaltrials.gov; NCT06694038). The primary outcome was incidence of post–endoscopic retrograde cholangiopancreatography (ERCP) pancreatitis. Secondary outcomes were biliary access success, time to biliary access, incidence of bleeding, and incidence of perforation.</div></div><div><h3>RESULTS</h3><div>Of the 137 procedures included in the study, 99 (72.3%) were carried out by advanced endoscopy trainees under supervision, 26 (19.0%) by advanced endoscopists without significant previous NKF experience, and 12 (8.8%) by an experienced advanced endoscopist with expertise in NKF. In the group that was randomized to SC, 6 (8.22%) patients developed pancreatitis vs 5 (7.81%) patients randomized to NKF arm (<em>P</em> = 0.93). Average time to biliary access within 20 minutes was significantly shorter with SC at 268 seconds (95% CI, 198-338 seconds) vs 380 seconds (95% CI, 292-466 seconds; <em>P</em> &lt; 0.05) in the NKF arm.</div></div><div><h3>CONCLUSION</h3><div>NKF is a safe and effective technique for primary biliary access during ERCP performed by advanced endoscopists with a wide range of experience, with post-ERCP pancreatitis equivalent to SC. NKF, in this study, took slightly longer than SC to achieve bile duct access. Use of either or both techniques resulted in a 100% successful bile duct cannulation in patients with favorable anatomy.</div></div>","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":"27 4","pages":"Article 250941"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144865231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
IF 0.9 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01
{"title":"","authors":"","doi":"","DOIUrl":"","url":null,"abstract":"","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":"27 3","pages":"Article 250924"},"PeriodicalIF":0.9,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"146242821","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic Ultrasound-guided Biliary Interventions 超声内镜下胆道介入治疗
IF 1.2 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 DOI: 10.1016/j.tige.2025.250916
Hiroyuki Isayama, Ko Tomishima, Shigeto Ishii, Yusuke Takasaki, Mako Ushio, Toshio Fujisawa
Endosonographic/endoscopic ultrasound–guided biliary drainage/anastomosis (EUS-BD/A) is widely accepted as a salvage procedure when conventional endoscopic retrograde cholangiopancreatography (ERCP) fails or is difficult. Although this procedure carries risks of severe adverse events (AEs), including perforation and bile leakage due to unattached organs, the risk of postprocedural pancreatitis in EUS-BD/A is extremely low. The intrahepatic bile duct approach is more challenging than extrahepatic because it involves penetrating the liver parenchyma. To establish EUS-BD/A as a standard primary biliary drainage procedure, it is essential to confirm its feasibility compared with ERCP, evaluate expanded indications, develop dedicated devices, and establish AE management strategies. EUS-BD/A showed similar technical and clinical success rates and AE rates, with ERCP and incidence of pancreatitis was significantly lower. Expanded indications for EUS-BD/A include primary drainage, preoperative use, pediatric patients, patients with massive ascites, and reintervention for stent occlusion; however, further evidence is required to support these indications. The development of devices to improve technical success and reduce AE rates is critical to establishing this procedure, but current devices remain insufficient for EUS-BD/A. In Japan, dedicated devices for EUS-BD/A include sharp-tip bougie dilators, drill-type dilators, sharp-tip balloon dilators, and covered self-expandable metallic stents with effective anchoring. Reducing the gap between the device and guidewire is particularly important for endosonographic/endoscopic ultrasound–guided hepaticogastrostomy. Management of AEs and the establishment of follow-up strategies are crucial as well. We herein summarize the prevention and management of AEs, including mediastinitis due to esophageal puncture, bile leakage, bleeding, and perforation, and introduce our follow-up strategy. Our ultimate goal is to establish EUS-BD/A as a standard primary biliary drainage procedure. Continuous efforts are necessary to advance various aspects of EUS-BD/A.
超声内镜/超声内镜引导胆道引流/吻合术(EUS-BD/A)被广泛接受为常规内镜逆行胆管造影(ERCP)失败或困难时的一种救助性手术。尽管该手术存在严重不良事件(ae)的风险,包括未附着器官引起的穿孔和胆漏,但EUS-BD/A术后胰腺炎的风险极低。肝内胆管入路比肝外胆管入路更具挑战性,因为它需要穿透肝实质。为了将EUS-BD/A作为标准的初级胆道引流手术,必须与ERCP进行比较,确认其可行性,评估扩大适应症,开发专用设备,建立AE管理策略。EUS-BD/A的技术和临床成功率和AE率相似,ERCP和胰腺炎发生率明显较低。EUS-BD/A的扩大适应症包括初级引流、术前使用、儿科患者、大量腹水患者和支架闭塞的再干预;然而,需要进一步的证据来支持这些适应症。提高技术成功率和降低AE率的设备的开发对于建立这一程序至关重要,但目前的设备仍然不足以满足EUS-BD/A。在日本,用于EUS-BD/A的专用设备包括尖尖膨胀式扩张器、钻式扩张器、尖尖球囊式扩张器和有效锚定的有盖自膨胀金属支架。减少器械与导丝之间的间隙对于超声内镜下肝胃造口术尤为重要。ae的管理和后续战略的制定也至关重要。我们在此总结ae的预防和处理,包括食管穿刺、胆漏、出血和穿孔引起的纵隔炎,并介绍我们的随访策略。我们的最终目标是建立EUS-BD/A作为标准的初级胆道引流手术。需要继续努力推进eu - bd /A的各个方面。
{"title":"Endoscopic Ultrasound-guided Biliary Interventions","authors":"Hiroyuki Isayama,&nbsp;Ko Tomishima,&nbsp;Shigeto Ishii,&nbsp;Yusuke Takasaki,&nbsp;Mako Ushio,&nbsp;Toshio Fujisawa","doi":"10.1016/j.tige.2025.250916","DOIUrl":"10.1016/j.tige.2025.250916","url":null,"abstract":"<div><div>Endosonographic/endoscopic ultrasound–guided biliary drainage/anastomosis (EUS-BD/A) is widely accepted as a salvage procedure when conventional endoscopic retrograde cholangiopancreatography (ERCP) fails or is difficult. Although this procedure carries risks of severe adverse events (AEs), including perforation and bile leakage due to unattached organs, the risk of postprocedural pancreatitis in EUS-BD/A is extremely low. The intrahepatic bile duct approach is more challenging than extrahepatic because it involves penetrating the liver parenchyma. To establish EUS-BD/A as a standard primary biliary drainage procedure, it is essential to confirm its feasibility compared with ERCP, evaluate expanded indications, develop dedicated devices, and establish AE management strategies. EUS-BD/A showed similar technical and clinical success rates and AE rates, with ERCP and incidence of pancreatitis was significantly lower. Expanded indications for EUS-BD/A include primary drainage, preoperative use, pediatric patients, patients with massive ascites, and reintervention for stent occlusion; however, further evidence is required to support these indications. The development of devices to improve technical success and reduce AE rates is critical to establishing this procedure, but current devices remain insufficient for EUS-BD/A. In Japan, dedicated devices for EUS-BD/A include sharp-tip bougie dilators, drill-type dilators, sharp-tip balloon dilators, and covered self-expandable metallic stents with effective anchoring. Reducing the gap between the device and guidewire is particularly important for endosonographic/endoscopic ultrasound–guided hepaticogastrostomy. Management of AEs and the establishment of follow-up strategies are crucial as well. We herein summarize the prevention and management of AEs, including mediastinitis due to esophageal puncture, bile leakage, bleeding, and perforation, and introduce our follow-up strategy. Our ultimate goal is to establish EUS-BD/A as a standard primary biliary drainage procedure. Continuous efforts are necessary to advance various aspects of EUS-BD/A.</div></div>","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":"27 2","pages":"Article 250916"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143785197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Understanding Patients’ Current Acceptability of Artificial Intelligence During Colonoscopy for Polyp Detection: A Single-Center Study 了解患者目前在结肠镜检查息肉时对人工智能的接受程度:一项单中心研究
IF 1.2 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 DOI: 10.1016/j.tige.2024.250905
Kathryn A. Schmidt , Shubham Sood , Saam Dilmaghani , Cadman Leggett , Ross Dierkhising , Mayank Goyal , Barbara A. Barry , Xuan Zhu , Nayantara Coelho-Prabhu

BACKGROUND AND AIMS

Research into potential applications of artificial intelligence (AI) in healthcare have witnessed a meteoric rise. A primary application in gastroenterological care is colonoscopy. Before AI tools become ubiquitous in healthcare, it is critical to appreciate the perspective of the potential beneficiaries, particularly patients. This study evaluated patient acceptability of AI in colonoscopy, particularly for polyp detection and diagnosis.

METHODS

In this cross-sectional survey study, patients undergoing outpatient colon cancer screening or surveillance colonoscopies at Mayo Clinic, Rochester, from September 2023 to February 2024 completed an electronic self-administered survey via tablet computer including questions regarding AI in colonoscopy. The primary outcome was patient perspectives on AI, and secondary outcomes included patient factors influencing their perspective. Statistical analyses were performed using Pearson's chi-square test and ordinal logistic regression.

RESULTS

Five hundred eight participants completed the survey. Younger age, male gender, and higher education were associated with higher AI familiarity and perceived importance, while males and those who believed in AI's positive outcomes were more comfortable with AI-assisted polyp detection.

CONCLUSION

This study is the first to assess patient perceptions of AI in colonoscopy. While patients generally believe AI can improve health outcomes, there is uncertainty about its current use, indicating a gap in knowledge and awareness. Key findings highlight that beliefs in AI's efficacy are linked to increased comfort with AI-assisted procedures, with significant demographic variations in perceptions, particularly across gender, age, and education. Addressing disparities through targeted education and transparent communication is crucial for fostering patient acceptance and trust in AI-assisted colonoscopy.
背景和目的人工智能(AI)在医疗保健领域的潜在应用研究正在迅速兴起。结肠镜检查是胃肠病学护理的主要应用。在人工智能工具在医疗保健领域普及之前,了解潜在受益者(尤其是患者)的观点至关重要。本研究评估了患者对人工智能在结肠镜检查中的可接受性,特别是对息肉的检测和诊断。方法在这项横断面调查研究中,2023年9月至2024年2月在罗切斯特梅奥诊所接受门诊结肠癌筛查或监测结肠镜检查的患者通过平板电脑完成了一项电子自我调查,包括结肠镜检查中人工智能的问题。主要结局是患者对人工智能的看法,次要结局包括影响其看法的患者因素。统计学分析采用皮尔逊卡方检验和有序逻辑回归。结果共有580名参与者完成了调查。年龄较小、男性性别和高等教育程度与人工智能的熟悉程度和感知重要性相关,而男性和那些相信人工智能积极结果的人对人工智能辅助息肉检测更满意。结论:本研究首次评估患者对结肠镜检查中人工智能的认知。虽然患者普遍认为人工智能可以改善健康状况,但其目前的用途存在不确定性,这表明在知识和意识方面存在差距。主要研究结果强调,对人工智能功效的信念与人工智能辅助手术的舒适度增加有关,在观念上存在显著的人口差异,特别是在性别、年龄和教育方面。通过有针对性的教育和透明的沟通来解决差异,对于促进患者对人工智能辅助结肠镜检查的接受和信任至关重要。
{"title":"Understanding Patients’ Current Acceptability of Artificial Intelligence During Colonoscopy for Polyp Detection: A Single-Center Study","authors":"Kathryn A. Schmidt ,&nbsp;Shubham Sood ,&nbsp;Saam Dilmaghani ,&nbsp;Cadman Leggett ,&nbsp;Ross Dierkhising ,&nbsp;Mayank Goyal ,&nbsp;Barbara A. Barry ,&nbsp;Xuan Zhu ,&nbsp;Nayantara Coelho-Prabhu","doi":"10.1016/j.tige.2024.250905","DOIUrl":"10.1016/j.tige.2024.250905","url":null,"abstract":"<div><h3>BACKGROUND AND AIMS</h3><div>Research into potential applications of artificial intelligence (AI) in healthcare have witnessed a meteoric rise. A primary application in gastroenterological care is colonoscopy. Before AI tools become ubiquitous in healthcare, it is critical to appreciate the perspective of the potential beneficiaries, particularly patients. This study evaluated patient acceptability of AI in colonoscopy, particularly for polyp detection and diagnosis.</div></div><div><h3>METHODS</h3><div>In this cross-sectional survey study, patients undergoing outpatient colon cancer screening or surveillance colonoscopies at Mayo Clinic, Rochester, from September 2023 to February 2024 completed an electronic self-administered survey via tablet computer including questions regarding AI in colonoscopy. The primary outcome was patient perspectives on AI, and secondary outcomes included patient factors influencing their perspective. Statistical analyses were performed using Pearson's chi-square test and ordinal logistic regression.</div></div><div><h3>RESULTS</h3><div>Five hundred eight participants completed the survey. Younger age, male gender, and higher education were associated with higher AI familiarity and perceived importance, while males and those who believed in AI's positive outcomes were more comfortable with AI-assisted polyp detection.</div></div><div><h3>CONCLUSION</h3><div>This study is the first to assess patient perceptions of AI in colonoscopy. While patients generally believe AI can improve health outcomes, there is uncertainty about its current use, indicating a gap in knowledge and awareness. Key findings highlight that beliefs in AI's efficacy are linked to increased comfort with AI-assisted procedures, with significant demographic variations in perceptions, particularly across gender, age, and education. Addressing disparities through targeted education and transparent communication is crucial for fostering patient acceptance and trust in AI-assisted colonoscopy.</div></div>","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":"27 2","pages":"Article 250905"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143349020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Endoscopic Ultrasound-Guided Gallbladder Drainage for Acute Cholecystitis and for Expanded Indications: Technique and Outcomes 超声内镜下胆囊引流治疗急性胆囊炎及扩大适应症:技术和结果
IF 1.2 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 DOI: 10.1016/j.tige.2025.250912
Andrea Anderloni , Cecilia Binda , Aurelio Mauro , Stefano Mazza , Carlo Fabbri , Anthony Y.B. Teoh
Interventional endoscopic ultrasound (EUS) is constantly evolving, thanks to its efficacy for the treatment of several clinical conditions, leading to an extension of applications and indications over the years. Among these, endoscopic ultrasound-guided gallbladder drainage (EUS-GBD) has become the preferred treatment for acute cholecystitis (AC) in high surgical risk patients, thanks to the introduction of electrocautery-enhanced lumen-apposing metal stents, which allowed a higher standardization of the technique, although still improving. Despite the significant progress made over the past 10 years, there are still a number of debated issues, above all due to application of this technique in a wider variety of broadened indications, beyond AC. Indeed, increasing evidences are emerging on EUS-GBD as treatment in case of distant malignant biliary obstruction in both primary and rescue scenarios. Additionally, there is preliminary evidence on AC prevention following the implantation of fully-covered self-expandable metal stents during endoscopic retrograde cholangiopancreatography in the malignant setting and on the treatment of gallstone-related diseases in not surgically fit patients. With an emphasis on technical considerations and outcomes, this review attempts to update the current indications for EUS-GBD and provide an overview of potential new fields of application for this technique.
介入内镜超声(EUS)不断发展,由于其治疗几种临床病症的疗效,导致多年来的应用和适应症的扩展。其中,超声内镜下胆囊引流术(EUS-GBD)已成为高手术风险患者急性胆囊炎(AC)的首选治疗方法,这是由于电灼增强腔内金属支架的引入,使得该技术的标准化程度更高,尽管仍在改进中。尽管在过去10年中取得了重大进展,但仍存在许多争议问题,首先是由于该技术在AC以外的更广泛适应症中的应用。确实,越来越多的证据表明EUS-GBD在原发性和抢救情况下可用于远处恶性胆道梗阻的治疗。此外,有初步证据表明,在恶性背景的内镜逆行胆管造影术中植入全覆盖自膨胀金属支架可预防AC,以及在不适合手术的患者中治疗胆结石相关疾病。本综述着重于技术考虑和结果,试图更新EUS-GBD目前的适应症,并概述该技术潜在的新应用领域。
{"title":"Endoscopic Ultrasound-Guided Gallbladder Drainage for Acute Cholecystitis and for Expanded Indications: Technique and Outcomes","authors":"Andrea Anderloni ,&nbsp;Cecilia Binda ,&nbsp;Aurelio Mauro ,&nbsp;Stefano Mazza ,&nbsp;Carlo Fabbri ,&nbsp;Anthony Y.B. Teoh","doi":"10.1016/j.tige.2025.250912","DOIUrl":"10.1016/j.tige.2025.250912","url":null,"abstract":"<div><div>Interventional endoscopic ultrasound (EUS) is constantly evolving, thanks to its efficacy for the treatment of several clinical conditions, leading to an extension of applications and indications over the years. Among these, endoscopic ultrasound-guided gallbladder drainage (EUS-GBD) has become the preferred treatment for acute cholecystitis (AC) in high surgical risk patients, thanks to the introduction of electrocautery-enhanced lumen-apposing metal stents, which allowed a higher standardization of the technique, although still improving. Despite the significant progress made over the past 10 years, there are still a number of debated issues, above all due to application of this technique in a wider variety of broadened indications, beyond AC. Indeed, increasing evidences are emerging on EUS-GBD as treatment in case of distant malignant biliary obstruction in both primary and rescue scenarios. Additionally, there is preliminary evidence on AC prevention following the implantation of fully-covered self-expandable metal stents during endoscopic retrograde cholangiopancreatography in the malignant setting and on the treatment of gallstone-related diseases in not surgically fit patients. With an emphasis on technical considerations and outcomes, this review attempts to update the current indications for EUS-GBD and provide an overview of potential new fields of application for this technique.</div></div>","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":"27 2","pages":"Article 250912"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143601225","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Distinct Breath Metabolome Signature Is Linked With Eosinophilic Esophagitis: A Proof-of-Concept Study Assessing Volatile Organic Compounds 独特的呼吸代谢组特征与嗜酸性粒细胞性食管炎有关:一项评估挥发性有机化合物的概念验证研究
IF 1.2 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 DOI: 10.1016/j.tige.2025.250913
CLAIRE A. BEVERIDGE , XUEFENG ZHANG , ANDREI I. IVANOV , JONATHAN MARK BROWN , SCOTT GABBARD , FLORIAN RIEDER
{"title":"A Distinct Breath Metabolome Signature Is Linked With Eosinophilic Esophagitis: A Proof-of-Concept Study Assessing Volatile Organic Compounds","authors":"CLAIRE A. BEVERIDGE ,&nbsp;XUEFENG ZHANG ,&nbsp;ANDREI I. IVANOV ,&nbsp;JONATHAN MARK BROWN ,&nbsp;SCOTT GABBARD ,&nbsp;FLORIAN RIEDER","doi":"10.1016/j.tige.2025.250913","DOIUrl":"10.1016/j.tige.2025.250913","url":null,"abstract":"","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":"27 2","pages":"Article 250913"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143601231","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Artificial Intelligence Advances Digital Pathomics for Confocal Endomicroscopy Diagnosis of Pancreatic Cysts 人工智能在胰腺囊肿共聚焦内镜诊断中的数字病理学进展
IF 1.2 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 DOI: 10.1016/j.tige.2025.250924
Ahmed Abdelbaki , Ziwei Li , Tai-Yu Pan , Justin Lee , Arpita Chowdhury , Stacey Culp , Bipul Gnyawali , Tassiana G. Maloof , Aayush B. Vishwanath , Sohil Narasimha Reddy , Dylan Mink , Wei Chen , Phil A. Hart , Timothy M. Pawlik , Wei-Lun Chao , Somashekar G. Krishna

BACKGROUND AND AIMS

Endoscopic ultrasound-guided needle-based confocal laser endomicroscopy (nCLE) provides real-time optical biopsies enabling diagnosis and risk stratification of intraductal papillary mucinous neoplasms (IPMNs). However, the clinical implementation of Endoscopic ultrasound-nCLE is hindered by time-consuming image review and interobserver variability. We aimed to optimize artificial intelligence (AI) models to accurately detect diagnostic structures to address these gaps.

METHODS

Participants with definitive IPMN diagnoses were selected from prospective studies (2015-2023). Two observers labeled endomicroscopy images used to develop AI models to detect informative segments. Performance was assessed using area under the curve, sensitivity, specificity, and accuracy.

RESULTS

In 66 endomicroscopy videos of IPMNs, 291,045 frames were analyzed, with 15.5% showing papillary or vascular structures and 84.5% lacking structures. Four classification (pattern recognition) and segmentation (image division) models were tested to evaluate binary detection outcomes (papillae vs other) and ternary detection outcomes (papillae, vascularity, and nonstructure). The classification model DINOv2-ViT-G outperformed all others for the binary outcome, achieving an area under the curve of 0.942, sensitivity of 80.6%, specificity of 90.6%, and accuracy of 89.3%. For the ternary outcome, only classification models were used because labeling areas for segmentation models to detect vascularity was impractical. DINOv2-ViT-G similarly demonstrated the best performance, with sensitivities for detecting papillae, vascularity, and nonstructure of 81.7%, 82.0%, and 80.5%, respectively. The DINOv2-ViT-G model reduced nCLE video duration to 1.85 minutes of high-yield, structure-containing segments, saving 4.27 minutes (70%) per IPMN case (P < 0.001).

CONCLUSION

Optimized AI models for structure identification enhance the clinical utility of nCLE by generating high-yield diagnostic segments, ensuring consistent and accurate interpretation, reducing manual effort, and enabling the development of fully autonomous systems in the future.
超声引导的针基共聚焦激光内镜(nCLE)提供实时光学活检,可用于导管内乳头状粘液瘤(IPMNs)的诊断和风险分层。然而,内窥镜超声- ncle的临床实施受到耗时的图像审查和观察者之间的差异的阻碍。我们的目标是优化人工智能(AI)模型,以准确地检测诊断结构,以解决这些差距。方法从前瞻性研究(2015-2023)中选择确诊IPMN的参与者。两名观察员标记了用于开发人工智能模型以检测信息片段的内窥镜图像。使用曲线下面积、灵敏度、特异性和准确性来评估性能。结果66个IPMNs内镜视频共分析291045帧,15.5%显示乳头状或血管结构,84.5%无结构。测试了四种分类(模式识别)和分割(图像分割)模型,以评估二值检测结果(乳头状体与其他)和三值检测结果(乳头状体、血管性和非结构性)。DINOv2-ViT-G分类模型在二元结果上优于其他分类模型,曲线下面积为0.942,灵敏度为80.6%,特异性为90.6%,准确率为89.3%。对于三元结果,只使用分类模型,因为标记区域的分割模型检测血管是不切实际的。DINOv2-ViT-G同样表现出最好的性能,对乳头、血管和非结构的检测灵敏度分别为81.7%、82.0%和80.5%。DINOv2-ViT-G模型将nCLE视频时间缩短至1.85分钟,高产量,含结构片段,每个IPMN病例节省4.27分钟(70%)(P <;0.001)。结论:优化后的人工智能模型可以生成高产量的诊断片段,确保一致和准确的解释,减少人工工作量,并使未来开发完全自主的系统成为可能,从而提高nCLE的临床应用。
{"title":"Artificial Intelligence Advances Digital Pathomics for Confocal Endomicroscopy Diagnosis of Pancreatic Cysts","authors":"Ahmed Abdelbaki ,&nbsp;Ziwei Li ,&nbsp;Tai-Yu Pan ,&nbsp;Justin Lee ,&nbsp;Arpita Chowdhury ,&nbsp;Stacey Culp ,&nbsp;Bipul Gnyawali ,&nbsp;Tassiana G. Maloof ,&nbsp;Aayush B. Vishwanath ,&nbsp;Sohil Narasimha Reddy ,&nbsp;Dylan Mink ,&nbsp;Wei Chen ,&nbsp;Phil A. Hart ,&nbsp;Timothy M. Pawlik ,&nbsp;Wei-Lun Chao ,&nbsp;Somashekar G. Krishna","doi":"10.1016/j.tige.2025.250924","DOIUrl":"10.1016/j.tige.2025.250924","url":null,"abstract":"<div><h3>BACKGROUND AND AIMS</h3><div>Endoscopic ultrasound-guided needle-based confocal laser endomicroscopy (nCLE) provides real-time optical biopsies enabling diagnosis and risk stratification of intraductal papillary mucinous neoplasms (IPMNs). However, the clinical implementation of Endoscopic ultrasound-nCLE is hindered by time-consuming image review and interobserver variability. We aimed to optimize artificial intelligence (AI) models to accurately detect diagnostic structures to address these gaps.</div></div><div><h3>METHODS</h3><div>Participants with definitive IPMN diagnoses were selected from prospective studies (2015-2023). Two observers labeled endomicroscopy images used to develop AI models to detect informative segments. Performance was assessed using area under the curve, sensitivity, specificity, and accuracy.</div></div><div><h3>RESULTS</h3><div>In 66 endomicroscopy videos of IPMNs, 291,045 frames were analyzed, with 15.5% showing papillary or vascular structures and 84.5% lacking structures. Four classification (pattern recognition) and segmentation (image division) models were tested to evaluate binary detection outcomes (papillae vs other) and ternary detection outcomes (papillae, vascularity, and nonstructure). The classification model DINOv2-ViT-G outperformed all others for the binary outcome, achieving an area under the curve of 0.942, sensitivity of 80.6%, specificity of 90.6%, and accuracy of 89.3%. For the ternary outcome, only classification models were used because labeling areas for segmentation models to detect vascularity was impractical. DINOv2-ViT-G similarly demonstrated the best performance, with sensitivities for detecting papillae, vascularity, and nonstructure of 81.7%, 82.0%, and 80.5%, respectively. The DINOv2-ViT-G model reduced nCLE video duration to 1.85 minutes of high-yield, structure-containing segments, saving 4.27 minutes (70%) per IPMN case (<em>P</em> &lt; 0.001).</div></div><div><h3>CONCLUSION</h3><div>Optimized AI models for structure identification enhance the clinical utility of nCLE by generating high-yield diagnostic segments, ensuring consistent and accurate interpretation, reducing manual effort, and enabling the development of fully autonomous systems in the future.</div></div>","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":"27 3","pages":"Article 250924"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144107531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Novel Cleansing Solution for High-Quality Upper Gastrointestinal Endoscopy: A Multicenter Randomized Controlled Trial 一种用于高质量上消化道内镜检查的新型清洁溶液:一项多中心随机对照试验
IF 1.2 Q4 GASTROENTEROLOGY & HEPATOLOGY Pub Date : 2025-01-01 DOI: 10.1016/j.tige.2025.250928
Noemi Gualandi , Giulia Gibiino , Giuliano Francesco Bonura , Matteo Secco , Paola Soriani , Alessandro Cucchetti , Cecilia Binda , Valentina Zadro , Pablo Cortegoso Valdivia , Paolo Biancheri , Mauro Manno , Carlo Fabbri

BACKGROUND AND AIMS

Esophagogastroduodenoscopy (EGD) is the gold standard examination for upper gastrointestinal (GI) disease diagnosis; however, intraluminal bubbles and mucus may reduce visibility. Mucolytic and tensioactive agents before EGD improve gastric visualization. We compared the efficacy of a novel cleansing preparation vs fasting on upper GI tract visualization during EGD.

METHODS

We conducted a multicenter, prospective, randomized controlled trial on consecutive adult outpatients undergoing EGD. Patients were randomized 1:1 to drink 50 mL of simethicone 150 mg, N-acetylcysteine 250 mg, and 10% acetic acid solution (Lumevis, Biofarmatec srl, Palermo, Italy) before the EGD or to fasting. The primary outcome was overall mucosal vision quality score, defined as the sum of 1-10 visual analog scale scores (0 = no visualization; 10 = perfect visualization) for each segment (esophagus, stomach, and duodenum) before washing. Secondary outcomes included adverse event rate, patient satisfaction, and EGD duration.

RESULTS

Patients were randomized to cleansing solution (n = 60) or fasting (n = 60). Cleansing preparation administration before EGD was associated with a higher overall mucosal vision quality score compared with fasting only (median visual analog scale score 23 [range, 21-25] vs 19 [range, 16-23], P = 0.001). No adverse events were reported in both groups. Patient satisfaction and EGD duration were similar between the cleansing preparation and fasting only.

CONCLUSION

Compared with fasting only, the administration of this novel cleansing solution was associated with improved mucosal visualization of the upper GI tract.
背景与目的食管胃十二指肠镜检查(EGD)是上消化道疾病诊断的金标准检查;然而,腔内气泡和粘液可能会降低能见度。EGD前使用粘液溶解剂和张力活性药物可改善胃显像。我们比较了一种新型清洁制剂与禁食对EGD期间上消化道显像的疗效。方法对连续接受EGD的成人门诊患者进行多中心、前瞻性、随机对照试验。患者按1:1的比例随机分配,在EGD前或禁食时饮用50 mL的西甲硅氧烷150 mg、n -乙酰半胱氨酸250 mg和10%的醋酸溶液(Lumevis, Biofarmatec srl, Palermo, Italy)。主要终点是粘膜视觉质量总分,定义为1-10个视觉模拟量表评分的总和(0 =无视觉;10 =完美的视觉效果)清洗前对每个节段(食道、胃和十二指肠)进行检查。次要结局包括不良事件发生率、患者满意度和EGD持续时间。结果患者随机分为洗液组(n = 60)和禁食组(n = 60)。与禁食相比,EGD前给予清洁制剂与更高的总体粘膜视觉质量评分相关(视觉模拟量表中位数评分为23[范围,21-25]对19[范围,16-23],P = 0.001)。两组均无不良事件发生。患者满意度和EGD持续时间在清洁制剂和禁食之间相似。结论:与单纯禁食相比,使用这种新型清洁液可改善上消化道粘膜的显像。
{"title":"A Novel Cleansing Solution for High-Quality Upper Gastrointestinal Endoscopy: A Multicenter Randomized Controlled Trial","authors":"Noemi Gualandi ,&nbsp;Giulia Gibiino ,&nbsp;Giuliano Francesco Bonura ,&nbsp;Matteo Secco ,&nbsp;Paola Soriani ,&nbsp;Alessandro Cucchetti ,&nbsp;Cecilia Binda ,&nbsp;Valentina Zadro ,&nbsp;Pablo Cortegoso Valdivia ,&nbsp;Paolo Biancheri ,&nbsp;Mauro Manno ,&nbsp;Carlo Fabbri","doi":"10.1016/j.tige.2025.250928","DOIUrl":"10.1016/j.tige.2025.250928","url":null,"abstract":"<div><h3>BACKGROUND AND AIMS</h3><div>Esophagogastroduodenoscopy (EGD) is the gold standard examination for upper gastrointestinal (GI) disease diagnosis; however, intraluminal bubbles and mucus may reduce visibility. Mucolytic and tensioactive agents before EGD improve gastric visualization. We compared the efficacy of a novel cleansing preparation vs fasting on upper GI tract visualization during EGD.</div></div><div><h3>METHODS</h3><div>We conducted a multicenter, prospective, randomized controlled trial on consecutive adult outpatients undergoing EGD. Patients were randomized 1:1 to drink 50 mL of simethicone 150 mg, N-acetylcysteine 250 mg, and 10% acetic acid solution (Lumevis, Biofarmatec srl, Palermo, Italy) before the EGD or to fasting. The primary outcome was overall mucosal vision quality score, defined as the sum of 1-10 visual analog scale scores (0 = no visualization; 10 = perfect visualization) for each segment (esophagus, stomach, and duodenum) before washing. Secondary outcomes included adverse event rate, patient satisfaction, and EGD duration.</div></div><div><h3>RESULTS</h3><div>Patients were randomized to cleansing solution (<em>n</em> = 60) or fasting (<em>n</em> = 60). Cleansing preparation administration before EGD was associated with a higher overall mucosal vision quality score compared with fasting only (median visual analog scale score 23 [range, 21-25] vs 19 [range, 16-23], <em>P</em> = 0.001). No adverse events were reported in both groups. Patient satisfaction and EGD duration were similar between the cleansing preparation and fasting only.</div></div><div><h3>CONCLUSION</h3><div>Compared with fasting only, the administration of this novel cleansing solution was associated with improved mucosal visualization of the upper GI tract.</div></div>","PeriodicalId":36169,"journal":{"name":"Techniques and Innovations in Gastrointestinal Endoscopy","volume":"27 3","pages":"Article 250928"},"PeriodicalIF":1.2,"publicationDate":"2025-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144298000","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Techniques and Innovations in Gastrointestinal Endoscopy
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1